Yamanaka, Kumiko
Haraguchi, Yuji
Takahashi, Hironobu
Kawashima, Ikko
Shimizu, Tatsuya http://orcid.org/0000-0001-7601-4239
Funding for this research was provided by:
MEXT | Japan Science and Technology Agency (JPMJMI20C1)
IntegriCulture, Inc.
MEXT | Japan Science and Technology Agency (JPMJMI20C1)
MEXT | Japan Science and Technology Agency (JPMJMI20C1)
IntegriCulture, Inc.
Article History
Received: 13 June 2022
Accepted: 4 January 2023
First Online: 10 January 2023
Competing interests
: Tokyo Women’s Medical University received research funds from IntegriCulture, Inc. I. Kawashima is the chief technology officer of IntegriCulture, Inc. The part of this manuscript describing the technique for culturing mammalian cells using culture supernatants is the subject of the following patent application: patent applicant (Tokyo Women’s Medical University and IntegriCulture, Inc.), name of inventors (T. Shimizu, Y. Haraguchi, K. Yamanaka and I. Kawashima), application number (P25490CO), status of application (pending). H. T. declares no financial competing interests. The authors have no relevant non-financial interests to disclose.